Recent Insights into Nanoparticulate Carrier Systems of Curcumin and its Clinical Perspective in the Management of Various Health Issues

Author:

Harwansh Ranjit K.1ORCID,Yadav Mukul1,Deshmukh Rohitas1,Rahman Akhlaquer2

Affiliation:

1. Institute of Pharmaceutical Research, GLA University, Mathura 281406, India

2. Department of Pharmaceutics, College of Pharmacy, Taif University, Kingdom of Saudi Arabia

Abstract

Abstract: Curcumin is a potent bioactive compound of Curcuma longa. Curcumin comprises a broad spectrum of biological activities, including hepatoprotective, anticancer, antimicrobial, anti-inflammatory, antitumor, anti- oxidant, etc. However, its low aqueous solubility, rapid excretion, and poor bioavailability restricted its therapeutic uses. To resolve these issues, novel nano-systems have now been developed to increase the bioactivity and bioavailability of curcumin by lowering the particle size, altering the surface, and increasing the efficacy of its encapsulation with various nanocarriers. Nanotechnology-based treatments can broaden the outlook for individuals with critical conditions. This article explores curcumin-based nanoparticulate carrier systems that should be employed to overcome this natural ingredient's inherent limitations. These nanocarriers also provide physical and chemical stability by encapsulating the drug into the core or matrix of the lipids or polymers. Nanotechnologists developed curcumin-encapsulated various nanoparticulate systems, including solid lipidic nanoparticles, polymeric nanoparticles, nano-structured lipid carriers, polymer conjugates, etc., to improve curcumin bioavailability and boost the sustained release of curcumin to target cells.

Publisher

Bentham Science Publishers Ltd.

Subject

Drug Discovery,Pharmacology

Reference194 articles.

1. Araújo M.C.; Antunes L.M.; Takahashi C.S.; Protective effect of thiourea, a hydroxyl-radical scavenger, on curcumin-induced chromosomal aberrations in an in vitro mammalian cell system. Teratog Carcinog Mutagen 2001,21(2),175-180

2. Aggarwal B.B.; Takada Y.; Oommen O.V.; From chemoprevention to chemotherapy: Common targets and common goals. Expert Opin Investig Drugs 2004,13(10),1327-1338

3. Basnet P.; Skalko-Basnet N.; Curcumin: An anti-inflammatory molecule from a curry spice on the path to cancer treatment. Molecules 2011,16(6),4567-4598

4. Jurenka J.S.; Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: A review of preclinical and clinical research. Altern Med Rev 2009,14(2),141-153

5. Kádasi A.; Sirotkin A.V.; Maruniaková N.; Kolesárová A.; Bulla J.; Grossmann RJJoM, Biotechnology, Sciences F. The effect of curcumin on secretory activity, proliferation and apoptosis of the porcine ovarian granulosa cells. J Microbiol Biotechnol Food Sci 2021,2021,349-357

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3